Thangamayil Jewellery Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:16 pm

Quick Insight

Thangamayil Jewellery Ltd's current market dynamics reveal a stock price of ₹1,977 with a market cap of ₹6,160 Cr. The company's P/E ratio stands at 57.1, indicating a relatively high valuation compared to industry peers. However, Thangamayil showcases healthy returns with an ROE of 14.9% and ROCE of 13.7%. The operational performance, reflected in an OPM of 6%, seems to have room for improvement. With substantial reserves of ₹1,071 Cr and moderate borrowings of ₹797 Cr, the company's financial structure appears stable. Shareholding distribution among promoters, FIIs, DIIs, and the public is balanced, fostering investor confidence. The high P/BV ratio of 5.66x suggests an optimistic market sentiment, while a comfortable ICR of 5.47x indicates the ability to meet debt obligations. Overall, Thangamayil Jewellery Ltd presents a mixed picture, warranting a closer look at operational efficiency and growth prospects to justify its current valuation.

Competitors of Thangamayil Jewellery Ltd

All Competitor Stocks of Thangamayil Jewellery Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:30 am

Below is a detailed analysis of the quarterly data for Thangamayil Jewellery Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,558.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,381.00 Cr. (Mar 2025) to 1,558.00 Cr., marking an increase of 177.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,471.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,323.00 Cr. (Mar 2025) to 1,471.00 Cr., marking an increase of 148.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 87.00 Cr.. The value appears strong and on an upward trend. It has increased from 57.00 Cr. (Mar 2025) to 87.00 Cr., marking an increase of 30.00 Cr..
• For OPM %, as of Jun 2025, the value is 6.00%. The value appears strong and on an upward trend. It has increased from 4.00% (Mar 2025) to 6.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Interest, as of Jun 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2025) to 65.00 Cr., marking an increase of 26.00 Cr..
• For Tax %, as of Jun 2025, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 30.00%, marking an increase of 11.00%.
• For Net Profit, as of Jun 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 15.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 14.71. The value appears strong and on an upward trend. It has increased from 10.10 (Mar 2025) to 14.71, marking an increase of 4.61.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:53 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:13 pm

Below is a detailed analysis of the balance sheet data for Thangamayil Jewellery Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2024) to 31.00 Cr., marking an increase of 4.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,071.00 Cr.. The value appears strong and on an upward trend. It has increased from 466.00 Cr. (Mar 2024) to 1,071.00 Cr., marking an increase of 605.00 Cr..
• For Borrowings, as of Mar 2025, the value is 797.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 532.00 Cr. (Mar 2024) to 797.00 Cr., marking an increase of 265.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 660.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 456.00 Cr. (Mar 2024) to 660.00 Cr., marking an increase of 204.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,559.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,481.00 Cr. (Mar 2024) to 2,559.00 Cr., marking an increase of 1,078.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 154.00 Cr. (Mar 2024) to 201.00 Cr., marking an increase of 47.00 Cr..
• For CWIP, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,347.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,325.00 Cr. (Mar 2024) to 2,347.00 Cr., marking an increase of 1,022.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,559.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,481.00 Cr. (Mar 2024) to 2,559.00 Cr., marking an increase of 1,078.00 Cr..

Notably, the Reserves (1,071.00 Cr.) exceed the Borrowings (797.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Thangamayil Jewellery Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 42.00. This value is within the healthy range. It has decreased from 44.91 (Mar 24) to 42.00, marking a decrease of 2.91.
• For Diluted EPS (Rs.), as of Mar 25, the value is 42.00. This value is within the healthy range. It has decreased from 44.91 (Mar 24) to 42.00, marking a decrease of 2.91.
• For Cash EPS (Rs.), as of Mar 25, the value is 45.82. This value is within the healthy range. It has decreased from 50.87 (Mar 24) to 45.82, marking a decrease of 5.05.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 354.68. It has increased from 179.73 (Mar 24) to 354.68, marking an increase of 174.95.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 354.68. It has increased from 179.73 (Mar 24) to 354.68, marking an increase of 174.95.
• For Dividend / Share (Rs.), as of Mar 25, the value is 12.50. This value exceeds the healthy maximum of 3. It has increased from 10.00 (Mar 24) to 12.50, marking an increase of 2.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,579.98. It has increased from 1,394.60 (Mar 24) to 1,579.98, marking an increase of 185.38.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 72.29. This value is within the healthy range. It has decreased from 79.36 (Mar 24) to 72.29, marking a decrease of 7.07.
• For PBIT / Share (Rs.), as of Mar 25, the value is 64.67. This value is within the healthy range. It has decreased from 73.40 (Mar 24) to 64.67, marking a decrease of 8.73.
• For PBT / Share (Rs.), as of Mar 25, the value is 51.45. This value is within the healthy range. It has decreased from 60.16 (Mar 24) to 51.45, marking a decrease of 8.71.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 38.19. This value is within the healthy range. It has decreased from 44.91 (Mar 24) to 38.19, marking a decrease of 6.72.
• For PBDIT Margin (%), as of Mar 25, the value is 4.57. This value is below the healthy minimum of 10. It has decreased from 5.69 (Mar 24) to 4.57, marking a decrease of 1.12.
• For PBIT Margin (%), as of Mar 25, the value is 4.09. This value is below the healthy minimum of 10. It has decreased from 5.26 (Mar 24) to 4.09, marking a decrease of 1.17.
• For PBT Margin (%), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 10. It has decreased from 4.31 (Mar 24) to 3.25, marking a decrease of 1.06.
• For Net Profit Margin (%), as of Mar 25, the value is 2.41. This value is below the healthy minimum of 5. It has decreased from 3.22 (Mar 24) to 2.41, marking a decrease of 0.81.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.76. This value is below the healthy minimum of 15. It has decreased from 24.98 (Mar 24) to 10.76, marking a decrease of 14.22.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.60. This value is within the healthy range. It has decreased from 31.92 (Mar 24) to 16.60, marking a decrease of 15.32.
• For Return On Assets (%), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 5. It has decreased from 8.32 (Mar 24) to 4.63, marking a decrease of 3.69.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.23 (Mar 24) to 0.06, marking a decrease of 0.17.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.68. This value is within the healthy range. It has decreased from 1.01 (Mar 24) to 0.68, marking a decrease of 0.33.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.43. It has decreased from 2.81 (Mar 24) to 2.43, marking a decrease of 0.38.
• For Current Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 1.54 (Mar 24) to 1.72, marking an increase of 0.18.
• For Quick Ratio (X), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 24) to 0.25, marking an increase of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.33. This value is below the healthy minimum of 4. It has increased from 3.16 (Mar 24) to 3.33, marking an increase of 0.17.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 15.58 (Mar 24) to 0.00, marking a decrease of 15.58.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 13.76 (Mar 24) to 0.00, marking a decrease of 13.76.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 84.42 (Mar 24) to 0.00, marking a decrease of 84.42.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 86.24 (Mar 24) to 0.00, marking a decrease of 86.24.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.47. This value is within the healthy range. It has decreased from 5.99 (Mar 24) to 5.47, marking a decrease of 0.52.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.89. This value is within the healthy range. It has decreased from 4.39 (Mar 24) to 3.89, marking a decrease of 0.50.
• For Enterprise Value (Cr.), as of Mar 25, the value is 6,747.79. It has increased from 3,954.63 (Mar 24) to 6,747.79, marking an increase of 2,793.16.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has increased from 1.03 (Mar 24) to 1.37, marking an increase of 0.34.
• For EV / EBITDA (X), as of Mar 25, the value is 30.03. This value exceeds the healthy maximum of 15. It has increased from 18.16 (Mar 24) to 30.03, marking an increase of 11.87.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 0.92 (Mar 24) to 1.27, marking an increase of 0.35.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 84.41 (Mar 24) to 0.00, marking a decrease of 84.41.
• For Price / BV (X), as of Mar 25, the value is 5.66. This value exceeds the healthy maximum of 3. It has decreased from 7.17 (Mar 24) to 5.66, marking a decrease of 1.51.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 0.92 (Mar 24) to 1.27, marking an increase of 0.35.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness